Clinical Scorecard: Mount Sinai Cancer Diagnostics Go AI-Powered

At a Glance

Key Highlights

• Implementation of AI-powered platform for genomic testing
• Reduction in manual analysis time for genomic variants
• Enhanced testing turnaround time for treatment decisions
• Support for precision oncology through improved insights
• Integration of AI tools to improve patient outcomes

Guideline-Based Recommendations

Diagnosis

• Utilize AI for detecting complex genomic variants

Management

• Implement AI-driven insights to inform treatment plans

Monitoring & Follow-up

• Track improvements in testing turnaround times and treatment decisions

Risks

• Consider potential limitations of AI in clinical decision-making

Patient & Prescribing Data

Oncology patients with blood cancers and solid tumors

Faster identification of genomic variants leading to timely treatment

Clinical Best Practices

• Adopt AI tools to enhance genomic testing efficiency
• Focus on precision oncology to improve patient outcomes
• Leverage recovered clinician time for patient-specific decision-making

References

• Mount Sinai Health System